C22H28N2O2
Neat
352.48
Room Temperature
57327-92-1; (-)-(14alpha)-Dihydrovinpocetine; (-)-Dihydroapovincaminic acid ethyl ester; 1E09UMT0FC; ethyl (15S, 17R, 19S)-15-ethyl-1, 11-diazapentacyclo[9.6.2.02, 7.08, 18.015, 19]nonadeca-2, 4, 6, 8(18)-tetraene-17-carboxylate; (-)-(14alpha)-Dihydrovinpocetine-d5; 1H-Indolo(3, 2, 1-de)pyrido(3, 2, 1-ij)(1, 5)naphthyridine-12-carboxylic acid, 13a-ethyl-2, 3, 5, 6, 12, 13, 13a, 13b-octahydro-, ethyl ester, (12R, 13aS, 13bS)-; Ethyl (12R, 13aS, 13bS)-13a-ethyl-2, 3, 5, 6, 12, 13, 13a, 13b-octahydro-1H-indolo(3, 2, 1-de)pyrido(3, 2, 1-ij)(1, 5)naphthyridine-12-carboxylate; Ethyl (41S, 12R, 13aS)-13a-ethyl-2, 3, 41, 5, 6, 12, 13, 13a-octahydro-1H-indolo[3, 2, 1-de]pyrido[3, 2, 1-ij][1, 5]naphthyridine-12-carboxylate; Dihydrovinpocetine, (-)-(14alpha)-; UNII-1E09UMT0FC; 1H-Indolo[3, 2, 1-de]pyrido[3, 2, 1-ij][1, 5]naphthyridine-12-carboxylic acid, 13a-ethyl-2, 3, 5, 6, 12, 13, 13a, 13b-octahydro-, ethyl ester, (12R, 13aS, 13bS)-; Vinpocetine impurity D; Vincamine Impurity 11; SCHEMBL10571107; DTXSID001100499; MSK10861; (-)-(14.ALPHA.)-DIHYDROVINPOCETINE; DIHYDROVINPOCETINE and (-)-(14.ALPHA.)-; Q27252308
ethyl (15S, 17R, 19S)-15-ethyl-1, 11-diazapentacyclo[9.6.2.02, 7.08, 18.015, 19]nonadeca-2, 4, 6 and 8(18)-tetraene-17-carboxylate
InChI=1S/C22H28N2O2/c1-3-22-11-7-12-23-13-10-16-15-8-5-6-9-17(15)24(19(16)20(22)23)18(14-22)21(25)26-4-2/h5-6,8-9,18,20H,3-4,7,10-14H2,1-2H3/t18-,20-,22+/m1/s1